SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011200
Filing Date
2024-08-07
Accepted
2024-08-07 07:13:54
Documents
89
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aplt-20240630x10q.htm   iXBRL 10-Q 2064922
2 EX-3.1 aplt-20240630xex3d1.htm EX-3.1 36870
3 EX-3.2 aplt-20240630xex3d2.htm EX-3.2 6366
4 EX-10.5 aplt-20240630xex10d5.htm EX-10.5 272763
5 EX-31.1 aplt-20240630xex31d1.htm EX-31.1 13001
6 EX-31.2 aplt-20240630xex31d2.htm EX-31.2 13892
7 EX-32.1 aplt-20240630xex32d1.htm EX-32.1 5831
8 EX-32.2 aplt-20240630xex32d2.htm EX-32.2 5928
  Complete submission text file 0001558370-24-011200.txt   8995970

Data Files

Seq Description Document Type Size
9 EX-101.SCH aplt-20240630.xsd EX-101.SCH 68582
10 EX-101.CAL aplt-20240630_cal.xml EX-101.CAL 48188
11 EX-101.DEF aplt-20240630_def.xml EX-101.DEF 304025
12 EX-101.LAB aplt-20240630_lab.xml EX-101.LAB 514059
13 EX-101.PRE aplt-20240630_pre.xml EX-101.PRE 491801
91 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20240630x10q_htm.xml XML 1316941
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38898 | Film No.: 241181413
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)